• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 RNA 测序和 Ingenuity 通路分析对乳泌素垂体神经内分泌肿瘤进行转录组谱分析。

Transcriptomic Profiling of Lactotroph Pituitary Neuroendocrine Tumors via RNA Sequencing and Ingenuity Pathway Analysis.

机构信息

Department of Anatomy and Neurobiology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Department of Neurological Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

出版信息

Neuroendocrinology. 2024;114(7):670-680. doi: 10.1159/000539017. Epub 2024 Apr 23.

DOI:10.1159/000539017
PMID:38643763
Abstract

INTRODUCTION

Lactotroph pituitary neuroendocrine tumors (PitNETs) are common pituitary tumors, but their underlying molecular mechanisms remain unclear. This study aimed to investigate the transcriptomic landscape of lactotroph PitNETs and identify potential molecular mechanisms and therapeutic targets through RNA sequencing and ingenuity pathway analysis (IPA).

METHODS

Lactotroph PitNET tissues from five surgical cases without dopamine agonist treatment underwent RNA sequencing. Normal pituitary tissues from 3 patients served as controls. Differentially expressed genes (DEGs) were identified, and the functional pathways and gene networks were explored by IPA.

RESULTS

Transcriptome analysis revealed that lactotroph PitNETs had gene expression patterns that were distinct from normal pituitary tissues. We identified 1,172 upregulated DEGs, including nine long intergenic noncoding RNAs (lincRNAs) belonging to the top 30 DEGs. IPA of the upregulated DEGs showed that the estrogen receptor signaling, oxidative phosphorylation signaling, and EIF signaling were activated. In gene network analysis, key upstream regulators, such as EGR1, PRKACA, PITX2, CREB1, and JUND, may play critical roles in lactotroph PitNETs.

CONCLUSION

This study provides a comprehensive transcriptomic profile of lactotroph PitNETs and highlights the potential involvement of lincRNAs and specific signaling pathways in tumor pathogenesis. The identified upstream regulators may be potential therapeutic targets for future investigations.

摘要

简介

催乳素细胞垂体神经内分泌肿瘤(PitNETs)是常见的垂体肿瘤,但它们的潜在分子机制仍不清楚。本研究旨在通过 RNA 测序和 Ingenuity 通路分析(IPA),研究催乳素细胞 PitNETs 的转录组图谱,并确定潜在的分子机制和治疗靶点。

方法

对五例未经多巴胺激动剂治疗的手术催乳素细胞 PitNET 组织进行 RNA 测序。以 3 例正常垂体组织作为对照。通过 IPA 识别差异表达基因(DEGs),并探讨其功能途径和基因网络。

结果

转录组分析显示,催乳素细胞 PitNETs 的基因表达模式与正常垂体组织明显不同。我们共鉴定出 1172 个上调的 DEGs,其中包括 9 个属于前 30 个 DEGs 的长非编码 RNA(lncRNA)。上调 DEGs 的 IPA 分析表明,雌激素受体信号、氧化磷酸化信号和 EIF 信号被激活。在基因网络分析中,EGR1、PRKACA、PITX2、CREB1 和 JUND 等关键上游调节剂可能在催乳素细胞 PitNETs 中发挥重要作用。

结论

本研究提供了催乳素细胞 PitNETs 的全面转录组图谱,并强调了 lncRNA 和特定信号通路在肿瘤发病机制中的潜在作用。鉴定出的上游调节剂可能是未来研究的潜在治疗靶点。

相似文献

1
Transcriptomic Profiling of Lactotroph Pituitary Neuroendocrine Tumors via RNA Sequencing and Ingenuity Pathway Analysis.通过 RNA 测序和 Ingenuity 通路分析对乳泌素垂体神经内分泌肿瘤进行转录组谱分析。
Neuroendocrinology. 2024;114(7):670-680. doi: 10.1159/000539017. Epub 2024 Apr 23.
2
Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNET.单细胞转录组学将基因表达特征与促性腺激素和催乳素 PitNET 的临床病理特征联系起来。
J Transl Med. 2024 Nov 15;22(1):1027. doi: 10.1186/s12967-024-05821-4.
3
Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.14q32.2 上的 DLK1/MEG3 基因座的功能特征揭示了垂体神经内分泌肿瘤的分化。
Aging (Albany NY). 2020 Dec 29;13(1):1422-1439. doi: 10.18632/aging.202376.
4
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.染色体不稳定性在垂体神经内分泌肿瘤预后预测中的作用。
Acta Neuropathol Commun. 2020 Nov 10;8(1):190. doi: 10.1186/s40478-020-01067-5.
5
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.基于全基因组表达分析的垂体神经内分泌肿瘤注释。
Acta Neuropathol Commun. 2021 Nov 10;9(1):181. doi: 10.1186/s40478-021-01284-6.
6
Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.转录组分析确定侵袭性无功能垂体神经内分泌肿瘤诊断的肿瘤亚型 mRNA 分类器。
Theranostics. 2021 Jan 1;11(1):132-146. doi: 10.7150/thno.47525. eCollection 2021.
7
Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.CDKN2A 缺失在高危垂体神经内分泌肿瘤中的频率和作用。
Endocr Pathol. 2020 Jun;31(2):166-173. doi: 10.1007/s12022-020-09609-2.
8
Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors.垂体神经内分泌肿瘤的单细胞转录组和基因组分析。
Neuro Oncol. 2021 Nov 2;23(11):1859-1871. doi: 10.1093/neuonc/noab102.
9
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs.LCM-RNAseq 突出显示 GH 分泌性垂体神经瘤存档组织中的肿瘤内异质性和长链非编码 RNA 特征。
Genes (Basel). 2024 Oct 31;15(11):1426. doi: 10.3390/genes15111426.
10
Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.鉴定与垂体神经内分泌肿瘤发生相关的增强子 RNA。
Front Endocrinol (Lausanne). 2023 Jul 18;14:1149997. doi: 10.3389/fendo.2023.1149997. eCollection 2023.

引用本文的文献

1
The evolution and application of multi-omic analysis for pituitary neuroendocrine tumors.垂体神经内分泌肿瘤多组学分析的进展与应用
Front Med (Lausanne). 2025 Sep 1;12:1629621. doi: 10.3389/fmed.2025.1629621. eCollection 2025.
2
Transcriptome analysis of the aged SAMP8 mouse model of Alzheimer's disease reveals novel molecular targets of formononetin protection.对阿尔茨海默病衰老SAMP8小鼠模型的转录组分析揭示了芒柄花素保护作用的新分子靶点。
Front Pharmacol. 2024 Aug 21;15:1440515. doi: 10.3389/fphar.2024.1440515. eCollection 2024.